Source: StreetInsider

Press Release: Casma : Casma Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) --...

Read full article »

Casma's Competitors | Casma's News | Casma's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

President & CEO

Frank Gentile

CEO Approval Rating

83/100

Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.